2021 Bakar Labs Golden Ticket

Details

AbbVie and Bakar Labs invite entrepreneurial scientists and founders to apply for a 2021 Bakar Labs Golden Ticket, sponsored by AbbVie. The Golden Ticket provides a year’s use of a lab bench and core facilities at Bakar Labs, as well as opportunities to engage with AbbVie scientific and business leaders. Two Golden Tickets will be awarded to early-stage companies developing novel, transformational therapies for oncology, or autoimmune, neurodegenerative, or ophthalmologic disease.

The deadline to apply for the 2021 cycle is 5 pm PT on Friday, June 25. Applications are now closed.

The Golden Ticket program is intended to be transformational for your company. In your application, please be sure to address how a Golden Ticket would impact your company’s aims.

Selected applicants will be invited to present their company to a select group of Bakar Labs advisors and AbbVie leadership via Zoom on Thursday, August 12.

Timeline

Applications are due by Friday, June 25.

Applicants on the shortlist will be notified by Wednesday, July 28.

The shortlist will present to the judging panel via Zoom on Thursday, August 12.

The winner will be announced after the pitch session on August 12.

Eligibility

This competition is open to life science entrepreneurs who are commercializing, or intend to commercialize, technologies addressing needs in oncology, or autoimmune, neurodegenerative, or ophthalmologic disease.

Companies with university affiliation are eligible; so are companies that have no university affiliation.

Teams at the pre-commercial (i.e. not yet incorporated) stage are eligible.

Companies seeking seed-stage through Series A funding are eligible.

We are looking for companies for whom winning a Golden Ticket will significantly impact their ability to advance.

We intend that this lab space be used by the winning company as its primary site of operations.